UK Healthcare IT Investment Opportunities

Analysis and Forecasts to 2012

Product Code GMD07518
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 125
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

UK Healthcare IT Investment Opportunities

Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to UK healthcare IT market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key segments of the healthcare IT in UK

Scope

  • The report provides healthcare IT information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, end users, and company shares.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the healthcare IT devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Healthcare IT
        • 2.2.1.1 Hospital Information Systems (HIS)
        • 2.2.1.2 Storage and Communication Systems
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
    • 3.3 Healthcare Policy
  • 4 Healthcare IT in United Kingdom
    • 4.1 Healthcare IT Overall Revenues (2000-2012)
    • 4.2 Healthcare IT Overall Company Share (2006-2007)
  • 5 Hospital Information Systems in United Kingdom
    • 5.1 Hospital Information Systems Overall Revenues (2000-2012)
      • 5.1.1 Electronic Medical Records Overall Revenues (2000-2012)
      • 5.1.2 Practice Management Overall Revenues (2000-2012)
      • 5.1.3 Computerized Physician Order Entry Overall Revenues (2000-2012)
    • 5.2 Hospital Information Systems Distribution Share (2006-2007)
    • 5.3 Hospital Information Systems Company Share (2006-2007)
  • 6 Storage and Communication Systems in United Kingdom
    • 6.1 Storage and Communication Systems Overall Revenues (2000-2012)
      • 6.1.1 PACS Overall Revenues (2000-2012)
      • 6.1.2 RIS Overall Revenues (2000-2012)
    • 6.2 Storage and Communication Systems Distribution Share (2006-2007)
    • 6.3 Storage and Communication Systems Company Share (2006-2007)
  • 7 iSOFT Group plc Company Profile
    • 7.1 Company Overview
    • 7.2 Business Overview
      • 7.2.1 Products
      • 7.2.2 History
    • 7.3 Locations And Subsidiaries
  • 8 Siemens Medical Solutions Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
      • 8.2.1 Siemens Medical
        • 8.2.1.1 Overview
        • 8.2.1.2 Financials
        • 8.2.1.3 Market View
        • 8.2.1.4 Key Strategies
      • 8.2.2 Products
      • 8.2.3 History
    • 8.3 Value Chain Analysis
      • 8.3.1 Manufacturing
        • 8.3.1.1 In House Manufacturing
        • 8.3.1.2 Outsourcing
      • 8.3.2 Product Development
        • 8.3.2.1 Regulatory Approvals
        • 8.3.2.2 Clinical Trials
        • 8.3.2.3 Research and Development
      • 8.3.3 Sales and Marketing
        • 8.3.3.1 Partnerships and Alliances
        • 8.3.3.2 E-distribution
    • 8.4 SWOT Analysis
      • 8.4.1 Siemens Medical Solutions Strengths
        • 8.4.1.1 Expertise in technology
        • 8.4.1.2 Strong product portfolio
        • 8.4.1.3 Global presence
      • 8.4.2 Siemens Medical Solutions Weaknesses
        • 8.4.2.1 Focus on in vitro diagnostics
      • 8.4.3 Siemens Medical Solutions Opportunities
        • 8.4.3.1 New product launches
        • 8.4.3.2 Acquisitions
        • 8.4.3.3 Strategic partnerships
      • 8.4.4 Siemens Medical Solutions Threats
        • 8.4.4.1 Change in market conditions
        • 8.4.4.2 Introduction of innovative technologies
        • 8.4.4.3 Huge competition
    • 8.5 Locations and Subsidiaries
    • 8.6 Siemens Medical Solutions Pipeline Products
      • 8.6.1 Acuson S2000
        • 8.6.1.1 Product Overview
        • 8.6.1.2 Product Description
        • 8.6.1.3 Product Status
        • 8.6.1.4 Product Milestone
      • 8.6.2 Syngo DynaCT
        • 8.6.2.1 Product Overview
        • 8.6.2.2 Product Description
        • 8.6.2.3 Product Status
        • 8.6.2.4 Product Milestone
      • 8.6.3 Syngo iGuide
        • 8.6.3.1 Product Overview
        • 8.6.3.2 Product Description
        • 8.6.3.3 Product Status
      • 8.6.4 Syngo iPilot
        • 8.6.4.1 Product Overview
        • 8.6.4.2 Product Description
        • 8.6.4.3 Product Status
      • 8.6.5 Siemens 7T MRI system
        • 8.6.5.1 Product Overview
        • 8.6.5.2 Product Description
        • 8.6.5.3 Product Status
      • 8.6.6 Siemens 11.7T MRI system
        • 8.6.6.1 Product Overview
        • 8.6.6.2 Product Description
        • 8.6.6.3 Product Status
      • 8.6.7 REMIND platform - REMIND Clinical Decision Support (CDS)
        • 8.6.7.1 Product Overview
        • 8.6.7.2 Product Description
        • 8.6.7.3 Product Status
        • 8.6.7.4 Product Milestone
      • 8.6.8 Synapse PACS (expanded data model)
        • 8.6.8.1 Product Overview
        • 8.6.8.2 Product Description
        • 8.6.8.3 Product Status
      • 8.6.9 Virtual Touch tissue imaging
        • 8.6.9.1 Product Overview
        • 8.6.9.2 Product Description
        • 8.6.9.3 Product Status
        • 8.6.9.4 Product Milestone
        • 8.6.9.5 Product Patent Details
      • 8.6.10 Virtual Touch tissue quantification
        • 8.6.10.1 Product Overview
        • 8.6.10.2 Product Description
        • 8.6.10.3 Product Status
        • 8.6.10.4 Product Patent Details
  • 9 McKesson Corporation Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
      • 9.2.1 Medical-Surgical Solutions
        • 9.2.1.1 Overview
        • 9.2.1.2 Financials
      • 9.2.2 Pharmaceutical Solutions
        • 9.2.2.1 Overview
        • 9.2.2.2 Financials
      • 9.2.3 Provider Technologies
        • 9.2.3.1 Overview
        • 9.2.3.2 Financials
      • 9.2.4 Products
      • 9.2.5 History
    • 9.3 Value Chain Analysis
      • 9.3.1 Manufacturing
        • 9.3.1.1 In House Manufacturing
      • 9.3.2 Product Development
        • 9.3.2.1 Regulatory Approvals
        • 9.3.2.2 Research and Development
      • 9.3.3 Sales and Marketing
        • 9.3.3.1 Partnerships and Alliances
        • 9.3.3.2 Licensing Agreements
    • 9.4 SWOT Analysis
      • 9.4.1 McKesson Corporation Strengths
        • 9.4.1.1 Strong market position
        • 9.4.1.2 Growing provider technologies division
        • 9.4.1.3 Value added offerings
      • 9.4.2 McKesson Corporation Weaknesses
        • 9.4.2.1 High dependence on the U.S
        • 9.4.2.2 Weak sales growth
      • 9.4.3 McKesson Corporation Opportunities
        • 9.4.3.1 Aging U.S. population
        • 9.4.3.2 Expanding generics market
        • 9.4.3.3 Acquisitions
      • 9.4.4 McKesson Corporation Threats
        • 9.4.4.1 Stiff competition
        • 9.4.4.2 Loss of key customers
        • 9.4.4.3 Re-importation of drugs
    • 9.5 Financial and Operational Review
      • 9.5.1 Financial Statements
      • 9.5.2 Financial Ratios
    • 9.6 Locations and Subsidiaries
  • 10 Medical Information Technology, Inc. Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Products
      • 10.2.2 History
    • 10.3 Locations and Subsidiaries
  • 11 Misys Healthcare Systems, Inc. Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Products
      • 11.2.2 History
    • 11.3 Locations and Subsidiaries
  • 12 Regulation System
    • 12.1 Medical Equipment Approval Process
      • 12.1.1 Classification of Medical Devices
      • 12.1.2 Conformity Assessment Process
        • 12.1.2.1 Class I devices
        • 12.1.2.2 Class IIa devices
        • 12.1.2.3 Class IIb devices
        • 12.1.2.4 Class III devices
    • 12.2 Medical Device approval fee
    • 12.3 Post Market Surveillance (PMS)
  • 13 Pricing and Reimbursement
    • 13.1 Market Pricing
    • 13.2 Government Policies for Reimbursement
  • 14 Distribution Structure
  • 15 Financial Deals Landscape
    • 15.1 Acquisition
      • 15.1.1 Philips Medical Systems Acquires TOMCAT Systems
      • 15.1.2 IBA Health Acquires iSoft Group
    • 15.2 Partnership
      • 15.2.1 HTH Worldwide Enters Into An Agreement With Hogg Robinson Group
      • 15.2.2 EQ2 Signs Distribution Agreement With BCAS Biomedical
  • 16 Recent Developments
    • 16.1 Strategy And Business Planning
      • 16.1.1 Jun 13, 2008: GE Healthcare Plans To Establish A Regional Headquarters In Istanbul, Turkey
      • 16.1.2 May 22, 2008: GE Healthcare And Satyam Announces Alliance
    • 16.2 Corporate Communications
      • 16.2.1 Aug 01, 2008: iSOFT Appoints Group Director, Enterprise Healthcare
      • 16.2.2 Jul 17, 2008: GE Health Care Appoints New CEO
      • 16.2.3 May 29, 2008: Premier Research Appoints Executive Director, Global Head Of Medical Management And Safety
      • 16.2.4 Apr 24, 2008: LiDCO Appoints Group Finance Director
    • 16.3 Product News
      • 16.3.1 Aug 27, 2008: Sunquest Releases Anatomic Pathology System In UK
  • 17 Appendix
    • 17.1 Global Markets Direct Research Methodology
    • 17.2 Coverage
    • 17.3 Secondary Research
    • 17.4 Primary Research
    • 17.5 Models
    • 17.6 Forecasts
    • 17.7 Expert Panels
    • 17.8 Currency Conversion
    • 17.9 Contact Us
    • 17.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 3: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 4: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 5: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 6: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 7: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 8: Healthcare IT, United Kingdom, Overall Company Share by Revenue ($ mn), 2006-2007
    • Table 9: Hospital Information Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 10: Hospital Information Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 11: Hospital Information Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 12: Hospital Information Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 13: Electronic Medical Records, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 14: Electronic Medical Records, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 15: Practice Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 16: Practice Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 17: Computerized Physician Order Entry, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 18: Computerized Physician Order Entry, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 19: Hospital Information Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 20: Hospital Information Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Storage and Communication Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 22: Storage and Communication Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 23: Storage and Communication Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 24: Storage and Communication Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 25: PACS, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 26: PACS, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 27: RIS, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 28: RIS, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 29: Storage and Communication Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 30: Storage and Communication Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: iSOFT Group plc, Other Locations
    • Table 32: iSOFT Group plc, Other Locations(Contd..)
    • Table 33: Siemens Medical Solutions, SWOT Analysis
    • Table 34: Siemens Medical Solutions, Other Locations
    • Table 35: Siemens Medical Solutions, Subsidiaries
    • Table 36: McKesson Corporation, SWOT Analysis , 2007
    • Table 37: McKesson Corporation, Financial Statements, USD Million, 2003-2007
    • Table 38: McKesson Corporation, Financial Ratios, USD Million, 2003-2007
    • Table 39: McKesson Corporation, Other Locations
    • Table 40: McKesson Corporation, Other Locations(Contd..)
    • Table 41: Misys Healthcare Systems, Inc., Subsidiaries
    • Table 42: Medical Device Approval Fee in UK, 2006
    • Table 43: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 3: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 4: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 5: Healthcare IT, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 6: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 7: Healthcare IT, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 8: Healthcare IT, United Kingdom, Overall Company Share (%), 2007
    • Figure 9: Hospital Information Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 10: Hospital Information Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 11: Hospital Information Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 12: Hospital Information Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 13: Electronic Medical Records, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Electronic Medical Records, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Practice Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 16: Practice Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 17: Computerized Physician Order Entry, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 18: Computerized Physician Order Entry, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: Hospital Information Systems, United Kingdom, Company Share (%), 2007
    • Figure 20: Storage and Communication Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 21: Storage and Communication Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 22: Storage and Communication Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 23: Storage and Communication Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 24: PACS, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 25: PACS, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 26: RIS, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 27: RIS, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 28: Storage and Communication Systems, United Kingdom, Company Share (%), 2007
    • Figure 29: Siemens Medical Solutions, Value Chain Analysis
    • Figure 30: McKesson Corporation, Value Chain Analysis
    • Figure 31: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 32: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 33: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 34: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 35: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 36: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 37: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 38: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 39: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 40: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 41: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 42: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 43: Global Markets Direct Methodology